D. Wagner (Lund, Sweden), M. Faner Canet (Barcelona, Spain)
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice E. Marchal-Duval (Paris, France), A. Froidure (Bruxelles, Belgium), M. Jaillet (Paris, France), M. Ghanem (Paris, France), A. Joannes (Rennes, France), A. Maurac (Paris, France), K. Schirduan (Munich, Germany), F. Jaschinski (Munich, Germany), . Crestani (Paris, France), A. Mailleux (Paris, France)
| |
LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair S. van Riet, D. Ninaber (D.K.Ninaber@lumc.nl / Leiden University Medical Center,Leiden), R. Rottier (r.rottier@erasmusmc.nl / Erasmuc MC,Rotterdam), F. (C.M.A.H.Freund@lumc.nl / Leiden University Medical Center,Leiden), H. (P.S.Hiemstra@lumc.nl / Leiden University Medical Center,Leiden)
| |
Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease R. Costa (Munich, Germany), D. Wagner (Munich, Germany), M. De Santis (Munich, Germany), K. Bailey (Denver, United States of America), A. Doryab (Munich, Germany), K. Schorpp (Munich, Germany), I. Rothenaigner (Munich, Germany), C. Ota (Munich, Germany), H. Baarsma (Munich, Germany), M. Campillos (Munich, Germany), K. Hadian (Munich, Germany), M. Königshoff (Denver, United States of America)
| |
Immunomodulatory properties of Lung Resident Mesenchymal Stem Cells in patients with COPD T. Cruz (Barcelona, Spain), A. López-Giraldo (Barcelona, Spain), G. Noell (Barcelona, Spain), A. Agusti (Barcelona, Spain), M. Faner Canet (Barcelona, Spain)
| |
Cigarette smoke exposure decreases CFLAR expression in bronchial epithelium, augmenting susceptibility for cell death and DAMP release S. Pouwels (Groningen, Netherlands), A. Faiz (Groningen, Netherlands), I. Heijink (Groningen, Netherlands), C. Vermeulen (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands)
| |
Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro S. van Riet (Leiden, Netherlands), D. Ninaber (Leiden, Netherlands), R. Rottier (Rotterdam, Netherlands), C. Freund (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands)
| |
Equine decellularized lung: a potencial approche for regenerative medicine R. Palma (São Paulo, Brazil), A. Cereta (São Paulo, Brazil), G. Matias (São Paulo, Brazil), P. Fratini (São Paulo, Brazil), L. Guimarães (Sâo Paulo, Brazil), L. Oliveira (Anapolis, Brazil), R. Farre (Barcelona, Spain), M. Miglino (Sâo Paulo, Brazil)
| |
Regeneration of functional lung by adult human SOX9+ airway basal cell transplantation W. Zuo (Shanghai, China), T. Zhang (Hangzhou, China), T. Ren (Hangzhou, China)
| |
Increased proliferation of type 2 alveolar epithelial cells in a pneumonectomy model mice with a deletion of p16ink4a gene. B. Ribeiro Baptista (CRETEIL, France), M. Zysman (CRETEIL, France), R. Souktani (CRETEIL, France), C. Giffard (CRETEIL, France), M. Lize (Goettingen , Germany), S. Pons (CRETEIL, France), S. Lanone (CRETEIL, France), J. Boczkowski (CRETEIL, France), L. Boyer (CRETEIL, France)
| |
Effect of inhaled antioxidants on surfactant phospholipids under prolonged experimental hyperoxia I. Katovich (Minsk, Belarus), Z. Rutkouskaya (Minsk, Belarus), A. Tahanovich (Minsk, Belarus)
| |
Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge E. Lopez Rodriguez (Hannover, Germany), C. Laukamp (Hannover, Germany), L. Steffen (Hannover, Germany), M. Ochs (Hannover, Germany), L. Knudsen (Hannover, Germany)
| |
Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), L. Knudsen (Hanover , Germany), R. Schliep (Hanover , Germany), S. Müller (Bern, Switzerland), T. Geiser (Bern, Switzerland)
| |
The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo P. Khan (Basel, Switzerland), A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), L. Fang (Basel, Switzerland), F. Caldana (Bern, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), T. Geiser (Bern, Switzerland), K. Hostettler (Basel, Switzerland)
| |
GED-0507 as a novel anti-fibrotic treatment option for pulmonary fibrosis S. Speca (Lille, France), C. Dubuquoy (Lille, France), C. Rousseaux (Lille, France), E. Jadot (Lille, France), P. Desreumaux (Lille, France), P. Spagnolo (PADOVA, Italy)
| |
Phase 2B dose selection of BG00011 for the treatment of idiopathic pulmonary fibrosis (IPF) M. Arefayene (CAMBRIDGE, United States of America), M. Mouded (CAMBRIDGE, United States of America), C. Stebbins (CAMBRIDGE, United States of America), G. Zhao (CAMBRIDGE, United States of America), G. Song (CAMBRIDGE, United States of America), R. Christmann (CAMBRIDGE, United States of America), S. Violette (CAMBRIDGE, United States of America), D. Gallagher (CAMBRIDGE, United States of America)
| |
Scar-in-a-Jar, an in vitro screening tool for antifibrotics J. Sand (Herlev, Denmark), N. Gudmann (Herlev, Denmark), S. Rønnow (Herlev, Denmark), S. Brockbank (Aachen, Germany), S. Cruwys (Aachen, Germany), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark)
| |
Tissue engineering for regeneration in vivo of decellularized trachea scaffolds using a porcine model E. Barrera Ramírez (Juárez City, Mexico), R. Garrido Cardona (Juárez City, Mexico), E. Rico Escobar (Juárez City, Mexico), A. Martínez Martínez (Juárez City, Mexico), L. Plenge Tellechea (Juárez City, Mexico), A. Hernandez (Juárez City, Mexico), E. Vanegas Venegas (Juárez City, Mexico)
| |